Author:
Pickard A. Simon,Huynh Lynn,Ivanova Jasmina I.,Totev Todor,Graham Sophia,Mühlbacher Axel C.,Roy Anuja,Duh Mei Sheng
Funder
Novartis Pharmaceuticals Corporation
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference35 articles.
1. Aplastic Anemia and MDS International Foundation. Aplastic Anemia. (2016a).
http://www.aamds.org/diseases/aplastic-anemia
. Accessed 16 Sept 2016.
2. Aplastic Anemia and MDS International Foundation. Aplastic Anemia. Types. (2016b).
http://www.aamds.org/diseases/aplastic-anemia/types
. Accessed 16 Sept 2016.
3. Balducci, L. (2006). Transfusion independence in patients with myelodysplastic syndromes: Impact on outcomes and quality of life. Cancer, 106, 2087–2094.
https://doi.org/10.1002/cncr.21860
.
4. Burnett, H. F., Regier, D. A., Feldman, B. M., Miller, F. A., & Ungar, W. J. (2012). Parents' preferences for drug treatments in juvenile idiopathic arthritis: A discrete choice experiment. Arthritis care & research, 64, 1382–1391.
https://doi.org/10.1002/acr.21698
.
5. Desmond, R., et al. (2014). Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood, 123, 1818–1825.
https://doi.org/10.1182/blood-2013-10-534743
.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献